Thomas Catinazzo - Sep 27, 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Financial Officer
Signature
/s/ Brian Adams, as attorney-in-fact
Stock symbol
RLAY
Transactions as of
Sep 27, 2022
Transactions value $
-$10,069
Form type
4
Date filed
9/29/2022, 05:10 PM
Previous filing
Sep 8, 2022
Next filing
Nov 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$10.1K -443 -0.85% $22.73 51.8K Sep 27, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on September 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 44,281 shares underlying RSUs.